Adherence to corticosteroids and clinical outcomes in mepolizumab therapy for severe asthma.

Gráinne d'AnconaJoanne KavanaghCris RoxasLinda GreenMariana FernandesLouise ThomsonJaideep DhariwalAlexandra M NanzerAlexandra M NanzerBrian D Kent

Published in: The European respiratory journal (2020)

ICS nonadherence is common in severe eosinophilic asthma patients receiving mepolizumab, and is associated with a lesser reduction in OCS requirements and AER.

Keyphrases

chronic obstructive pulmonary disease
lung function
early onset
allergic rhinitis
glycemic control
type diabetes
drug induced